カテゴリー： Market Monitor Global, 世界, 医療/バイオ

植込み型神経刺激装置のグローバル市場展望 2023年-2029年：脊髄刺激（SCS）装置、脳深部刺激（DBS）装置、人工内耳、その他

◆英語タイトル：Implantable Neurostimulation System Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC13339）

◆商品コード：MMG23DC13339
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の植込み型神経刺激装置市場規模と予測を収録しています。・世界の植込み型神経刺激装置市場：売上、2018年-2023年、2024年-2029年
・世界の植込み型神経刺激装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の植込み型神経刺激装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「脊髄刺激（SCS）装置」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

植込み型神経刺激装置のグローバル主要企業は、Medtronic、 Abbott、 Nevro、 Boston Scientific、 Mainstay Medical、 Cochlear、 Nalu Medical、 LivaNova、 ReShape Lifesciences、 Inspire Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、植込み型神経刺激装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の植込み型神経刺激装置市場：タイプ別、2018年-2023年、2024年-2029年
世界の植込み型神経刺激装置市場：タイプ別市場シェア、2022年
・脊髄刺激（SCS）装置、脳深部刺激（DBS）装置、人工内耳、その他

世界の植込み型神経刺激装置市場：用途別、2018年-2023年、2024年-2029年
世界の植込み型神経刺激装置市場：用途別市場シェア、2022年
・病院&診療所、認知症ケアセンター、研究機関、その他

世界の植込み型神経刺激装置市場：地域・国別、2018年-2023年、2024年-2029年
世界の植込み型神経刺激装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における植込み型神経刺激装置のグローバル売上、2018年-2023年
・主要企業における植込み型神経刺激装置のグローバル売上シェア、2022年
・主要企業における植込み型神経刺激装置のグローバル販売量、2018年-2023年
・主要企業における植込み型神経刺激装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Medtronic、 Abbott、 Nevro、 Boston Scientific、 Mainstay Medical、 Cochlear、 Nalu Medical、 LivaNova、 ReShape Lifesciences、 Inspire Medical

*************************************************************

・調査・分析レポートの概要
植込み型神経刺激装置市場の定義
市場セグメント
世界の植込み型神経刺激装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の植込み型神経刺激装置市場規模
世界の植込み型神経刺激装置市場規模：2022年 VS 2029年
世界の植込み型神経刺激装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの植込み型神経刺激装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の植込み型神経刺激装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：脊髄刺激（SCS）装置、脳深部刺激（DBS）装置、人工内耳、その他
植込み型神経刺激装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院&診療所、認知症ケアセンター、研究機関、その他
植込み型神経刺激装置の用途別グローバル売上・予測

・地域別市場分析
地域別植込み型神経刺激装置市場規模 2022年と2029年
地域別植込み型神経刺激装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、 Abbott、 Nevro、 Boston Scientific、 Mainstay Medical、 Cochlear、 Nalu Medical、 LivaNova、 ReShape Lifesciences、 Inspire Medical
...

This research report provides a comprehensive analysis of the Implantable Neurostimulation System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Implantable Neurostimulation System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Implantable Neurostimulation System, challenges faced by the industry, and potential opportunities for market players.
The global Implantable Neurostimulation System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Implantable Neurostimulation System market presents opportunities for various stakeholders, including Hospitals & Clinics, Cognitive Care Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Implantable Neurostimulation System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Implantable Neurostimulation System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Implantable Neurostimulation System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Implantable Neurostimulation System market.
Market Overview: The report provides a comprehensive overview of the Implantable Neurostimulation System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Spinal Cord Stimulation (SCS) Systems, Deep Brain Stimulation (DBS) System), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Implantable Neurostimulation System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Implantable Neurostimulation System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Implantable Neurostimulation System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Implantable Neurostimulation System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Implantable Neurostimulation System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Implantable Neurostimulation System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Implantable Neurostimulation System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Implantable Neurostimulation System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Implantable Neurostimulation System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Spinal Cord Stimulation (SCS) Systems
Deep Brain Stimulation (DBS) System
Cochlear Implants
Others
Market segment by Application
Hospitals & Clinics
Cognitive Care Centers
Research Institutes
Others
Global Implantable Neurostimulation System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medtronic
Abbott
Nevro
Boston Scientific
Mainstay Medical
Cochlear
Nalu Medical
LivaNova
ReShape Lifesciences
Inspire Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Implantable Neurostimulation System, market overview.
Chapter 2: Global Implantable Neurostimulation System market size in revenue and volume.
Chapter 3: Detailed analysis of Implantable Neurostimulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Implantable Neurostimulation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Implantable Neurostimulation System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Implantable Neurostimulation System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Neurostimulation System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable Neurostimulation System Overall Market Size
2.1 Global Implantable Neurostimulation System Market Size: 2022 VS 2029
2.2 Global Implantable Neurostimulation System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Implantable Neurostimulation System Sales: 2018-2029
3 Company Landscape
3.1 Top Implantable Neurostimulation System Players in Global Market
3.2 Top Global Implantable Neurostimulation System Companies Ranked by Revenue
3.3 Global Implantable Neurostimulation System Revenue by Companies
3.4 Global Implantable Neurostimulation System Sales by Companies
3.5 Global Implantable Neurostimulation System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Implantable Neurostimulation System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Implantable Neurostimulation System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Neurostimulation System Players in Global Market
3.8.1 List of Global Tier 1 Implantable Neurostimulation System Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Neurostimulation System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Implantable Neurostimulation System Market Size Markets, 2022 & 2029
4.1.2 Spinal Cord Stimulation (SCS) Systems
4.1.3 Deep Brain Stimulation (DBS) System
4.1.4 Cochlear Implants
4.1.5 Others
4.2 By Type – Global Implantable Neurostimulation System Revenue & Forecasts
4.2.1 By Type – Global Implantable Neurostimulation System Revenue, 2018-2023
4.2.2 By Type – Global Implantable Neurostimulation System Revenue, 2024-2029
4.2.3 By Type – Global Implantable Neurostimulation System Revenue Market Share, 2018-2029
4.3 By Type – Global Implantable Neurostimulation System Sales & Forecasts
4.3.1 By Type – Global Implantable Neurostimulation System Sales, 2018-2023
4.3.2 By Type – Global Implantable Neurostimulation System Sales, 2024-2029
4.3.3 By Type – Global Implantable Neurostimulation System Sales Market Share, 2018-2029
4.4 By Type – Global Implantable Neurostimulation System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Implantable Neurostimulation System Market Size, 2022 & 2029
5.1.2 Hospitals & Clinics
5.1.3 Cognitive Care Centers
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application – Global Implantable Neurostimulation System Revenue & Forecasts
5.2.1 By Application – Global Implantable Neurostimulation System Revenue, 2018-2023
5.2.2 By Application – Global Implantable Neurostimulation System Revenue, 2024-2029
5.2.3 By Application – Global Implantable Neurostimulation System Revenue Market Share, 2018-2029
5.3 By Application – Global Implantable Neurostimulation System Sales & Forecasts
5.3.1 By Application – Global Implantable Neurostimulation System Sales, 2018-2023
5.3.2 By Application – Global Implantable Neurostimulation System Sales, 2024-2029
5.3.3 By Application – Global Implantable Neurostimulation System Sales Market Share, 2018-2029
5.4 By Application – Global Implantable Neurostimulation System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Implantable Neurostimulation System Market Size, 2022 & 2029
6.2 By Region – Global Implantable Neurostimulation System Revenue & Forecasts
6.2.1 By Region – Global Implantable Neurostimulation System Revenue, 2018-2023
6.2.2 By Region – Global Implantable Neurostimulation System Revenue, 2024-2029
6.2.3 By Region – Global Implantable Neurostimulation System Revenue Market Share, 2018-2029
6.3 By Region – Global Implantable Neurostimulation System Sales & Forecasts
6.3.1 By Region – Global Implantable Neurostimulation System Sales, 2018-2023
6.3.2 By Region – Global Implantable Neurostimulation System Sales, 2024-2029
6.3.3 By Region – Global Implantable Neurostimulation System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Implantable Neurostimulation System Revenue, 2018-2029
6.4.2 By Country – North America Implantable Neurostimulation System Sales, 2018-2029
6.4.3 US Implantable Neurostimulation System Market Size, 2018-2029
6.4.4 Canada Implantable Neurostimulation System Market Size, 2018-2029
6.4.5 Mexico Implantable Neurostimulation System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Implantable Neurostimulation System Revenue, 2018-2029
6.5.2 By Country – Europe Implantable Neurostimulation System Sales, 2018-2029
6.5.3 Germany Implantable Neurostimulation System Market Size, 2018-2029
6.5.4 France Implantable Neurostimulation System Market Size, 2018-2029
6.5.5 U.K. Implantable Neurostimulation System Market Size, 2018-2029
6.5.6 Italy Implantable Neurostimulation System Market Size, 2018-2029
6.5.7 Russia Implantable Neurostimulation System Market Size, 2018-2029
6.5.8 Nordic Countries Implantable Neurostimulation System Market Size, 2018-2029
6.5.9 Benelux Implantable Neurostimulation System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Implantable Neurostimulation System Revenue, 2018-2029
6.6.2 By Region – Asia Implantable Neurostimulation System Sales, 2018-2029
6.6.3 China Implantable Neurostimulation System Market Size, 2018-2029
6.6.4 Japan Implantable Neurostimulation System Market Size, 2018-2029
6.6.5 South Korea Implantable Neurostimulation System Market Size, 2018-2029
6.6.6 Southeast Asia Implantable Neurostimulation System Market Size, 2018-2029
6.6.7 India Implantable Neurostimulation System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Implantable Neurostimulation System Revenue, 2018-2029
6.7.2 By Country – South America Implantable Neurostimulation System Sales, 2018-2029
6.7.3 Brazil Implantable Neurostimulation System Market Size, 2018-2029
6.7.4 Argentina Implantable Neurostimulation System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Implantable Neurostimulation System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Implantable Neurostimulation System Sales, 2018-2029
6.8.3 Turkey Implantable Neurostimulation System Market Size, 2018-2029
6.8.4 Israel Implantable Neurostimulation System Market Size, 2018-2029
6.8.5 Saudi Arabia Implantable Neurostimulation System Market Size, 2018-2029
6.8.6 UAE Implantable Neurostimulation System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Neurostimulation System Major Product Offerings
7.1.4 Medtronic Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Implantable Neurostimulation System Major Product Offerings
7.2.4 Abbott Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Nevro
7.3.1 Nevro Company Summary
7.3.2 Nevro Business Overview
7.3.3 Nevro Implantable Neurostimulation System Major Product Offerings
7.3.4 Nevro Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.3.5 Nevro Key News & Latest Developments
7.4 Boston Scientific
7.4.1 Boston Scientific Company Summary
7.4.2 Boston Scientific Business Overview
7.4.3 Boston Scientific Implantable Neurostimulation System Major Product Offerings
7.4.4 Boston Scientific Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.4.5 Boston Scientific Key News & Latest Developments
7.5 Mainstay Medical
7.5.1 Mainstay Medical Company Summary
7.5.2 Mainstay Medical Business Overview
7.5.3 Mainstay Medical Implantable Neurostimulation System Major Product Offerings
7.5.4 Mainstay Medical Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.5.5 Mainstay Medical Key News & Latest Developments
7.6 Cochlear
7.6.1 Cochlear Company Summary
7.6.2 Cochlear Business Overview
7.6.3 Cochlear Implantable Neurostimulation System Major Product Offerings
7.6.4 Cochlear Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.6.5 Cochlear Key News & Latest Developments
7.7 Nalu Medical
7.7.1 Nalu Medical Company Summary
7.7.2 Nalu Medical Business Overview
7.7.3 Nalu Medical Implantable Neurostimulation System Major Product Offerings
7.7.4 Nalu Medical Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.7.5 Nalu Medical Key News & Latest Developments
7.8 LivaNova
7.8.1 LivaNova Company Summary
7.8.2 LivaNova Business Overview
7.8.3 LivaNova Implantable Neurostimulation System Major Product Offerings
7.8.4 LivaNova Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.8.5 LivaNova Key News & Latest Developments
7.9 ReShape Lifesciences
7.9.1 ReShape Lifesciences Company Summary
7.9.2 ReShape Lifesciences Business Overview
7.9.3 ReShape Lifesciences Implantable Neurostimulation System Major Product Offerings
7.9.4 ReShape Lifesciences Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.9.5 ReShape Lifesciences Key News & Latest Developments
7.10 Inspire Medical
7.10.1 Inspire Medical Company Summary
7.10.2 Inspire Medical Business Overview
7.10.3 Inspire Medical Implantable Neurostimulation System Major Product Offerings
7.10.4 Inspire Medical Implantable Neurostimulation System Sales and Revenue in Global (2018-2023)
7.10.5 Inspire Medical Key News & Latest Developments
8 Global Implantable Neurostimulation System Production Capacity, Analysis
8.1 Global Implantable Neurostimulation System Production Capacity, 2018-2029
8.2 Implantable Neurostimulation System Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Neurostimulation System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Implantable Neurostimulation System Supply Chain Analysis
10.1 Implantable Neurostimulation System Industry Value Chain
10.2 Implantable Neurostimulation System Upstream Market
10.3 Implantable Neurostimulation System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Neurostimulation System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 植込み型神経刺激装置のグローバル市場展望 2023年-2029年：脊髄刺激（SCS）装置、脳深部刺激（DBS）装置、人工内耳、その他(Implantable Neurostimulation System Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

植込み型神経刺激装置のグローバル市場展望 2023年-2029年：脊髄刺激（SCS）装置、脳深部刺激（DBS）装置、人工内耳、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp